Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mark Layton

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Plos Medicine|June 14, 2006
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiologyThomas G Smith, Jerome T Brooks, George M Balanos, et al.
The New England Journal of Medicine|September 5, 2019
Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F Grace, Christian Rose, D Mark Layton, et al.
Haematologica|October 15, 2020
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patientsPaul Telfer, Josu De la Fuente, Mamta Sohal, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Plos Medicine|June 14, 2006
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiologyThomas G Smith, Jerome T Brooks, George M Balanos, et al.
The New England Journal of Medicine|September 5, 2019
Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F Grace, Christian Rose, D Mark Layton, et al.
Haematologica|October 15, 2020
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patientsPaul Telfer, Josu De la Fuente, Mamta Sohal, et al.
Pageof 4